{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:30:41Z","timestamp":1757705441549},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1995,12,1]],"date-time":"1995-12-01T00:00:00Z","timestamp":817776000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[1995,12]]},"DOI":"10.1007\/bf03190244","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T00:56:55Z","timestamp":1281056215000},"page":"275-279","source":"Crossref","is-referenced-by-count":1,"title":["A comparative bioavailability study to estimate the influence of an antacid on droxicam pharmacokinetics"],"prefix":"10.1007","volume":"20","author":[{"given":"M. T.","family":"Maya","sequence":"first","affiliation":[]},{"given":"J. P.","family":"Pais","sequence":"additional","affiliation":[]},{"given":"J. Ruas","family":"Da Silva","sequence":"additional","affiliation":[]},{"given":"J. A.","family":"Morais","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"key":"BF03190244_CR1","first-page":"407","volume":"8","author":"A.J. Farr\u00e9","year":"1986","unstructured":"Farr\u00e9 A.J., Colombo M., Fort M., Gutierrez B., Rodriguez L., Roser R. (1986): Pharmacological properties of droxicam, a new non-steroidal antiinflammatory agent. Meth. Find. Exp. Clin. Pharmacol., 8, 407\u2013422.","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"BF03190244_CR2","first-page":"209","volume":"9","author":"J. Esteve","year":"1987","unstructured":"Esteve J., Martinez L., Roser R., Sagarra R. (1987): Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation. Meth. Find. Exp. Clin. Pharmacol., 9, 209\u2013213.","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"BF03190244_CR3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF03190116","volume":"14","author":"L. Martinez","year":"1989","unstructured":"Martinez L., Sanchez R., Garcia-Barbal J., Sagarra R., Bartlett A. (1989): Single and multiple dose pharmacokinetics of a new NSAID (droxicam) in healthy volunteers. Eur. J. Drug Metab. Pharmacokinet., 14, 303\u2013307.","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"BF03190244_CR4","first-page":"729","volume":"10","author":"L. Martinez","year":"1988","unstructured":"Martinez L., Sanchez R., Garcia-Barbal J., et al. (1988): Comparative study of the multiple dose pharmacokinetics and the tolerance of a new NSAID (droxicam) versus piroxicam in healthy volunteers. Meth. Find. Exp. Clin. Pharmacol., 10, 729\u2013737.","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"BF03190244_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0306-3623(88)90004-3","volume":"19","author":"J. Esteve","year":"1988","unstructured":"Esteve J., Farr\u00e9 A., Roser R. (1988): Pharmacological profile of droxicam. Gen. Pharmacol., 19, 49\u201354.","journal-title":"Gen. Pharmacol."},{"key":"BF03190244_CR6","doi-asserted-by":"crossref","unstructured":"Maya M.T., Pais J.P., Morais J. A. (1996): A rapid method for the determination of piroxicam in plasma by high-performance liquid chromatography. J. Pharm. Biomed. Anal., In press.","DOI":"10.1016\/0731-7085(95)01658-9"},{"key":"BF03190244_CR7","unstructured":"Retting-Zinke. (1989): Generica: a software package for Statistical analysis for bioavailability studies, version 3.0 Coesfeld."},{"key":"BF03190244_CR8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2307\/2529949","volume":"35","author":"W. Westlake","year":"1979","unstructured":"Westlake W. (1979): Statistical aspects of comparative bioavailability trials. Biometrics, 35, 273\u2013280.","journal-title":"Biometrics"},{"key":"BF03190244_CR9","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/BF01068419","volume":"15","author":"D. Schuirman","year":"1987","unstructured":"Schuirman D. (1987): A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm., 15, 657\u2013680.","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"BF03190244_CR10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1002\/jps.2600721018","volume":"72","author":"H. Fluehler","year":"1983","unstructured":"Fluehler H., Grieve A., Mandallaz D., Man J., Moser H., (1983): Bayesian approach to bioequivalence assessment: an example. J. Pharm. Sci., 72, 1178\u20131181.","journal-title":"J. Pharm. Sci."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03190244\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03190244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:59:33Z","timestamp":1558483173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03190244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1995,12]]}},"alternative-id":["BF03190244"],"URL":"https:\/\/doi.org\/10.1007\/bf03190244","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,12]]}}}